XV Konferencja Naukowa Polskiego Towarzystwa Hepatologicznego
News
Current issue
Archival Issues
Search
Newsletter
Manuscript Submission
 » 
Journal Abstract
 
Entecavir – new treatment in chronic hepatitis B
Waldemar Halota, Małgorzata Pawłowska
Medical Science Review - Hepatologia 2006; 6 15-16
aaICID: 449222
Article type: Original article
IC™ Value: 3.59
Abstract provided by Publisher
 
The authors present pharmacological and clinical data concerning a new nucleoside analog, Entecavir, in the treatment of chronic hepatitis B. In animals and in in vitro studies, entecavir greatly inhibited viral replication, especially in blocking HBV DNA-polimerase priming, reverse transcription of pregenomic mRNA, and HBV DNA synthesis. Entecavir is safe and effective in the treatment of chronic hepatits B in naïve HBeAg-positive and -negative patients as well as in patients with lamivudine resistance.

ICID 449222


Related articles
  • in IndexCopernicus™
         analogi nukleozydów [1 related records]


  •  

    Copyright © Medical Science Review - Hepatologia  2017
    Page created by Index Copernicus Ltd. All Rights reserved.